- Expertise article
- Philips et al., 2017
Porcine respiratory disease complex (PRDC) is a significant challenge for the global swine industry. PRDC includes both viral and bacterial respiratory pathogens, mainly Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus type 2 (PCV2), Mycoplasma hyopneumoniae (Mhp) and secondary bacterial agents. Vaccine derived immune protection against clinical disease associated with PRDC pathogens is one control intervention. The purpose of this controlled-experimental study was to evaluate pigs vaccinated with 3FLEX® (a trivalent PCV2, Mhp and PRRS vaccine) compared to a non-vaccinated group following a severe PRDC challenge.
Read the full publication here.